This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: Tesla, Fortinet, West Pharmaceutical Services, DexCom and Tractor Supply
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tesla, Fortinet, West Pharmaceutical Services, DexCom and Tractor Supply
PerkinElmer's Tie-Up to Boost Health Outcomes in Africa
by Zacks Equity Research
PerkinElmer's (PKI) partnership with ASH likely to boost newborn screening in underserved populations for better health outcomes in Africa.
5 S&P 500 Winners of 100 Days of Coronavirus Pandemic
by Sweta Killa
Today marks 100 days since the World Health Organization declared COVID-19 a pandemic on Mar 11. We have highlighted some stocks from the S&P 500 index that soared more than 40% during this period.
Accuray's New CyberKnife S7 System to Boost Patient Care
by Zacks Equity Research
Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.
5 Best Stocks From 100 Days of Coronavirus
by Tirthankar Chakraborty
Here're five big stock winners from the first 100 days of the coronavirus pandemic that ravaged the global economy and shook the stock market.
Buy These 5 Low Leverage Stocks to Avoid Debt-Related Risk
by Zacks Equity Research
Exorbitant debt financing might even cause a corporation's bankruptcy in the worst-case scenario.
Here's Why You Should Hold on to Intuitive Surgical Stock Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.
AMN Healthcare (AMN) Introduces New Customizable Offering
by Zacks Equity Research
AMN Healthcare (AMN) offers a customizable return-to-work solutions as businesses resume operations amid the ongoing pandemic.
Here's Why You Should Add AngioDynamics to Your Portfolio
by Zacks Equity Research
AngioDynamics (ANGO) continues to benefit from strategic buyouts and strong product portfolio.
HMS Holdings' Solution to Help Consumers Amid Coronavirus
by Zacks Equity Research
HMS Holdings (HMSY) offers a unique COVID-19 health management and communications solution to support consumers during the pandemic.
Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for JPME
DexCom's (DXCM) G6 CGM System Gets CE Marking in Europe
by Zacks Equity Research
DexCom (DXCM) announces the receipt of CE Marking across Europe for its G6 CGM System.
Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge
by Zacks Equity Research
Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge
Here's Why You Should Hold on to Stryker (SYK) Stock for Now
by Zacks Equity Research
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.
Top 3 Momentum Anomaly Stocks to Consider on Investor Optimism
by Zacks Equity Research
These frontrunners are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.
Here's Why You Should Retain NextGen Healthcare Stock Now
by Zacks Equity Research
NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and solid recurring revenue base.
Ecolab's AdvaCare Disinfectant Receives First EPA Approval
by Zacks Equity Research
Ecolab's (ECL) AdvaCare Disinfectant receives first EPA approval for a laundry disinfectant and oxidizer emerging viral pathogen claim that is effective against the coronavirus.
4 Sector ETFs & Stocks to Buy on Record Jobs Gain in May
by Sanghamitra Saha
The U.S. jobs report for the month of May reflected the largest one-month job gains.
Why You Should Retain PerkinElmer (PKI) in Your Portfolio
by Zacks Equity Research
PerkinElmer (PKI) continues to gain traction from strong international presence and robust product portfolio.
Zacks.com featured highlights include: Synopsys, Tesla, Chemed, Teekay Tankers and West Pharmaceutical Services
by Zacks Equity Research
Zacks.com featured highlights include: Synopsys, Tesla, Chemed, Teekay Tankers and West Pharmaceutical Services
Cerner & NCHC Alliance to Boost Behavioral Health Technology
by Zacks Equity Research
Cerner (CERN) has been selected by NCHC to implement its EHR across three multi-specialty facilities.
Buy These 5 Low Leverage Stocks to Invest Safely
by Zacks Equity Research
Debt financing is a feasible option as long as the companies succeed in generating a higher rate of return compared to the interest rate
Here's Why You Should Add DexCom (DXCM) to Your Portfolio
by Zacks Equity Research
DexCom (DXCM) continues to gain traction from strong international presence and robust product portfolio.
Zacks.com featured highlights include: West Pharmaceutical Services, Teradyne, Dollar General, Applied Materials and Kroger
by Zacks Equity Research
Zacks.com featured highlights include: West Pharmaceutical Services, Teradyne, Dollar General, Applied Materials and Kroger
Here's Why You Should Invest in OPKO Health (OPK) Stock Now
by Zacks Equity Research
OPKO Health (OPK) continues to gain traction from solid prospects in RAYALDEE and BioReference platforms.